Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: March 19, 2014 (revised April 7, 2014)

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Sovaldi	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Otrexup	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Brintellix	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Olysio	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Natroba	New Drug Appeal	Require Prior Approval	Prior Approval Required
Quillivant XR	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Linzess	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
TOBI Podhaler	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Abilify Maintena	PDL Appeal	Add to Preferred Status	Preferred and Require Prior Approval
Onglyza	PDL Appeal	Require Prior Approval	Prior Approval Required

Footer